Induction of cross-reactive, mucosal anti-SARS-CoV-2 antibody responses in rheumatoid arthritis patients after 3rd dose of COVID-19 vaccination

Systemic vaccination against SARS-CoV-2 elicited high titers of specific antibodies in the blood and in the oral cavity. Preexisting autoimmune diseases, such as rheumatoid arthritis, and biological treatments, like B cell depletion, are known to exhibit higher risk of severe COVID-19 manifestation...

Descripción completa

Detalles Bibliográficos
Autores principales: Bondareva, M., Letz, P., Karberg, K., Schrezenmeier, E., Semin, I., Rincon-Arevalo, H., Dörner, T., Mashreghi, M.F., Stefanski, A.-L., Kruglov, A.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550527/
https://www.ncbi.nlm.nih.gov/pubmed/36228431
http://dx.doi.org/10.1016/j.jaut.2022.102918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550527/
https://www.ncbi.nlm.nih.gov/pubmed/36228431
http://dx.doi.org/10.1016/j.jaut.2022.102918

Ejemplares similares